|Videos|August 3, 2017
What is the Goal of Treat-to-Target in Patients with Rheumatoid Arthritis?
What is the importance and prevalence of treat-to-target?
Advertisement
Marcus H. Snow, MD, from University of Nebraska Medical Center, speaks about the importance of treat-to-target and its goal of disease remission in patients with rheumatoid arthritis. Dr. Snow believes that most physicians already practice an informal treat-to-target therapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
5